These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12442883)

  • 1. A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months.
    Martin S; Lĵo H; Peuskens J; Thirumalai S; Giudicelli A; Fleurot O; Rein W;
    Curr Med Res Opin; 2002; 18(6):355-62. PubMed ID: 12442883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.
    Bhowmick S; Hazra A; Ghosh M
    Aust N Z J Psychiatry; 2010 Mar; 44(3):237-42. PubMed ID: 20050717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.
    Mortimer A; Martin S; Lôo H; Peuskens J;
    Int Clin Psychopharmacol; 2004 Mar; 19(2):63-9. PubMed ID: 15076013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
    Vanelle JM; Douki S
    Eur Psychiatry; 2006 Dec; 21(8):523-30. PubMed ID: 17113759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.
    Molina JD; Toledo-Romero F; López-Rodríguez E; Amorin-Díaz M; Lerma-Carrillo I; López-Muñoz F
    Pharmacopsychiatry; 2011 Jun; 44(4):142-7. PubMed ID: 21710404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical issues with amisulpride in the management of patients with schizophrenia.
    Pani L; Villagrán JM; Kontaxakis VP; Alptekin K
    Clin Drug Investig; 2008; 28(8):465-77. PubMed ID: 18598092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
    Wagner M; Quednow BB; Westheide J; Schlaepfer TE; Maier W; Kühn KU
    Neuropsychopharmacology; 2005 Feb; 30(2):381-90. PubMed ID: 15578006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.
    Peuskens J; De Hert M; Mortimer A;
    Int Clin Psychopharmacol; 2007 May; 22(3):145-52. PubMed ID: 17414740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.
    Lecrubier Y; Quintin P; Bouhassira M; Perrin E; Lancrenon S
    Acta Psychiatr Scand; 2006 Nov; 114(5):319-27. PubMed ID: 17022791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
    Hilger E; Kasper S
    Wien Klin Wochenschr; 2000 Dec; 112(24):1031-8. PubMed ID: 11204312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
    Geddes J; Freemantle N; Harrison P; Bebbington P
    BMJ; 2000 Dec; 321(7273):1371-6. PubMed ID: 11099280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.
    Riedel M; Eich FX; Möller HJ
    Eur Psychiatry; 2009 Apr; 24(3):149-53. PubMed ID: 19070995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
    J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study.
    Alvarez E; Bobes J; Gómez JC; Sacristán JA; Cañas F; Carrasco JL; Gascón J; Gibert J; Gutiérrez M;
    Eur Neuropsychopharmacol; 2003 Jan; 13(1):39-48. PubMed ID: 12480121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
    Mortimer AM; Joyce E; Balasubramaniam K; Choudhary PC; Saleem PT;
    Hum Psychopharmacol; 2007 Oct; 22(7):445-54. PubMed ID: 17691076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological approaches to the management of schizophrenia.
    Lambert TJ; Castle DJ
    Med J Aust; 2003 May; 178(S9):S57-61. PubMed ID: 12720524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amisulpride: a review of its use in the management of schizophrenia.
    McKeage K; Plosker GL
    CNS Drugs; 2004; 18(13):933-56. PubMed ID: 15521794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial].
    Jarema M; Olajossy M; Chrzanowski W; Araszkiewicz A; Landowski J; Rybakowski J; Bilikiewicz A; Bomba J; Debowska G
    Psychiatr Pol; 2003; 37(4):641-55. PubMed ID: 14560493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.